Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling
Cellular and Molecular Life Sciences · 2025-11-06 · 82 (1)
DOI: 10.1007/s00018-025-05916-1 ↗At a glance
Journal article in Cellular and Molecular Life Sciences, published online on 2025-11-06. Written by Lingjia Lu and 4 co-authors. Institution: Department of Obstetrics and Gynecology, Women's Hospital, Medicine School of Zhejiang University, 1 Xueshi Road, Shangcheng District, Hangzhou, Zhej…. Major MEDLINE topics: Uterine Cervical Neoplasms, Glycolysis, Octamer Transcription Factor-3, Calcium Signaling. Cited 2 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.
Abstract (original language)
Cervical cancer is a common cancer among women worldwide. It has been revealed that hypoxia contributes to the progression of cervical cancer. In our study, we discovered that hypoxia indeed promoted the malignant phenotypes of cervical cancer cells by enhancing glycolysis. Loss-of-function experiments showed that hypoxia treatment upregulated the octamer-binding transcriptional factor 4 (OCT4) expression via glycolysis. Through the RNA-sequence and enrichment analyses, we found that hypoxia induced the enrichment of the calcium signaling pathway and upregulation of Calcium Release-Activated Calcium Modulator 3 (ORAI3), which could be abrogated by silencing OCT4. Notably, overexpressing ORAI3 has similar effects on the malignant phenotypes of HeLa and SiHa cells as those of hypoxia. Furthermore, silencing ORAI3 or inactivating calcium signals significantly reversed OCT4-induced malignant progression of cervical cancer both in vitro and in vivo. ChIP and dual-luciferase reporter results confirmed that OCT4 contributed to the transcription of ORAI3. Mechanically, hypoxia upregulated OCT4 expression by facilitating glycolysis, and OCT4 overexpression enhanced the transcription of ORAI3, activating the calcium signaling pathway and ultimately promoting the malignant progression of cervical cancer. Our study reveals novel molecular mechanisms by which hypoxia induces the progression of cervical cancer, providing a new strategy for treating cervical cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetrics and Gynecology, Women's Hospital, Medicine School of Zhejiang University, 1 Xueshi Road, Shangcheng District, Hangzhou, Zhejiang, 310000, China.
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Medicine School of Zhejiang University, Hangzhou, Zhejiang, China.
- Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, Zhejiang, China.
- Department of Obstetrics and Gynecology, Women's Hospital, Medicine School of Zhejiang University, 1 Xueshi Road, Shangcheng District, Hangzhou, Zhejiang, 310000, China. 5315014@zju.edu.cn.
Funding
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
Cite
APA
Lu, L., Wang, F., Wang, T., Xing, Z., & Jiang, P. (2025). Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling. Cellular and Molecular Life Sciences, 82(1). https://doi.org/10.1007/s00018-025-05916-1
Vancouver
Lu L, Wang F, Wang T, Xing Z, Jiang P. Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling. Cellular and Molecular Life Sciences. 2025;82(1). doi:10.1007/s00018-025-05916-1
BibTeX
@article{Lu2025,
author = {Lu, Lingjia and Wang, Fenfen and Wang, Ting and Xing, Ziyu and Jiang, Peiyue},
title = {Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
volume = {82},
number = {1},
doi = {10.1007/s00018-025-05916-1}
}
EUVIMED